Drug Exposure and Susceptibility of Pyrazinamide Correlate with Treatment Response in Pyrazinamide-Susceptible Patients with Multidrug-Resistant Tuberculosis.

Authors:
Dong S; Shao G; Davies Forsman L; Wang S; Wang S and 7 more

Journal:
Pharmaceutics

Publication Year: 2024

DOI:
10.3390/pharmaceutics16010144

PMCID:
PMC10820138

PMID:
38276514

Journal Information

Full Title: Pharmaceutics

Abbreviation: Pharmaceutics

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Pharmacology & Pharmacy

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflicts of Interest The authors declare no conflicts of interest."

Evidence found in paper:

"The research was funded by Shanghai three-year (2023-2025) action plan to strengthen the public health system (Grant No. GWVI-11.1-05 to Y.H.), the National Natural Science Foundation of China (Grant No. 81874273 to Y. H.), the Science and Technology Project of Suzhou City Health Bureau (Grant No. LCZX201918, SLT2021010 to J.L.), and Suzhou Key Medical Center (Grant No. Szlcyxzx202108 to J.L.)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025